Zenith Capital Corp. (ZHCLF)
ZHCLF Stock Price Chart
Explore Zenith Capital Corp. interactive price chart. Choose custom timeframes to analyze ZHCLF price movements and trends.
ZHCLF Company Profile
Discover essential business fundamentals and corporate details for Zenith Capital Corp. (ZHCLF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 May 2021
Employees
—
CEO
Donald J. McCaffrey
Description
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. Its lead compound ZEN-3694 which is in Phase 2b clinical trials for the treatment of metastatic castration resistant prostate cancer and metastatic triple negative breast cancer. The company was formerly known as Zenith Epigenetics Corp. and changed its name to Zenith Capital Corp. in August 2016. The company was incorporated in 2013 and is headquartered in Calgary, Canada.
ZHCLF Financial Timeline
Browse a chronological timeline of Zenith Capital Corp. corporate events including earnings releases, dividend announcements, and stock splits.
ZHCLF Stock Performance
Access detailed ZHCLF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.